United States · FDA National Drug Code directory

Naproxen

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
70010-137_451b46b7-e6fb-8436-e063-6294a90adcf1
Product NDC
70010-137
Form
TABLET
Composition / generic term
Naproxen
Labeler
Granules Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20210415
Source listing expiry
20261231

Source-listed ingredients

  • NAPROXEN — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (70010-137-01) · 70010-137-01
  • 500 TABLET in 1 BOTTLE (70010-137-05) · 70010-137-05
  • 1000 TABLET in 1 BOTTLE (70010-137-10) · 70010-137-10

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Naproxen — United States | Molindra Medicines